Literature DB >> 6413484

The killing effects of cefathiamidine or ampicillin alone and in combination with gentamicin against enterococci.

H Y Chen, J D Williams.   

Abstract

The in-vitro activity of cefathiamidine against Streptococcus faecalis and Str. faecium were studied in comparison with other beta-lactams. All the 56 strains of Str. faecalis tested were inhibited by 2 mg/l of cefathiamidine. MICs of ampicillin were twofold higher than those of cefathiamidine and MICs of cephaloridine and cephazolin were 8-16-fold higher. No significant inoculum effect on MICs of cefathiamidine could be seen. Two isolates of Str. faecium showed resistance to the four antibiotics. The MBCs of cefathiamidine and ampicillin for ten strains of Str. faecalis showed that the ratios of MBC/MIC were greater than 64. The rates of killing of Str. faecalis were reduced at concentrations of cefathiamidine and ampicillin greater than the MIC. The most rapid killing was obtained at 2 mg/l cefathiamidine or 4 mg/l of ampicillin. With the addition of 1 mg/l gentamicin this paradoxical bacteriocidal effect was eliminated. Time killing studies showed 99.9% of the cells were killed within 6 h by a combination of aminoglycoside and beta-lactam. The paradoxical bacteriocidal effect of cefathiamidine and ampicillin was also demonstrated on solid media.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6413484     DOI: 10.1093/jac/12.1.19

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

Review 1.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

2.  The activity of vancomycin and teicoplanin alone and in combination with gentamicin or ampicillin against Streptococcus faecalis.

Authors:  H Y Chen; J D Williams
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

3.  In vitro activity of cephalosporin RWJ-54428 (MC-02479) against multidrug-resistant gram-positive cocci.

Authors:  Alan P Johnson; Marina Warner; Michael Carter; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

4.  In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics.

Authors:  R Fontana; A Grossato; M Ligozzi; E A Tonin
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

5.  Penicillin acylase-catalyzed synthesis of N-bromoacetyl-7-aminocephalosporanic acid, the key intermediate for the production of cefathiamidine.

Authors:  Xiao-Li Zhang; Min-Hua Zong; Ning Li
Journal:  Bioresour Bioprocess       Date:  2016-11-19

6.  Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.

Authors:  J P Maskell; A M Sefton; J Yong; S J Chi; J D Williams
Journal:  Infection       Date:  1988       Impact factor: 3.553

7.  Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance.

Authors:  Bin Du; Yue Zhou; Bo-Hao Tang; Yue-E Wu; Xin-Mei Yang; Hai-Yan Shi; Bu-Fan Yao; Guo-Xiang Hao; Dian-Ping You; John van den Anker; Yi Zheng; Wei Zhao
Journal:  Front Pharmacol       Date:  2021-03-15       Impact factor: 5.810

8.  Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection.

Authors:  Li-Juan Zhi; Li Wang; Zhong-Ren Shi; Wei Zhao; Xing-Kai Chen; Xiao-Ying Zhai; Li Wen; Lei Dong; Evelyne Jacqz-Aigrain
Journal:  Drug Des Devel Ther       Date:  2018-04-17       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.